Skip to main content

Table 1 Clinical characteristics of the patients at baseline

From: Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Baseline clinical characteristic

Patient nr. 150

Age (years)—mean ± SD

64.3 ± 10.4

Sex (male)—no. (%)

108 (72.0)

Race (Caucasian)—no. (%)

140 (93.3)

Body-mass index (kg/m2)—mean ± SD; no.

29.5 ± 5.1; 148a

Risk factors—no. (%)

 Diabetes mellitus type 1

10 (6.7)

 Diabetes mellitus type 2

140 (93.3)

 Insulin-dependent diabetes mellitus

47 (31.3)

 Diabetes mellitus treated with oral antidiabetic

117 (78.0)

 HbA1c (mmol/mol)—mean ± SD; no.

55.5 ± 11.5; 42a

 Arterial hypertension

104 (69.3)

 Hypercholesterolemia

100 (66.7)

 Family history of cardiovascular disease

59 (39.3)

 Current smoker

35 (23.3)

Medical history—no. (%)

 Previous ACS

41 (27.3)

 Previous PCI

37 (24.7)

 Previous CABG

8 (5.3)

 Previous CVA or TIA

10 (8.7)

 Severe chronic renal failureb

4 (2.7)

 Chronic pulmonary obstructive diseasec

11 (7.3)

Clinical presentation—no. (%)

 Acute coronary syndrome

73 (48.7)

  ST-segment elevation myocardial infarction

18 (12.0)

  Non-ST-segment elevation myocardial infarction

29 (19.3)

  Unstable angina pectoris

26 (17.3)

 Non-acute coronary syndrome

77 (51.3)

  Stable angina pectoris

59 (39.3)

  Silent ischemia

8 (5.3)

  Other

10 (6.7)

  1. Plus–minus values are means ± standard and the curved numbers a represent the known total of which the variable was calculated. b Renal insufficiency was defined as estimated glomerular filtration rate of less than 30 ml per minute per 1.73 m2 of body surface area (GFR < 30 ml/min/1.73 m2). c Chronic pulmonary obstructive disease was defined as ≥ Gold class II
  2. ACS acute coronary syndrome, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, CVA cerebrovascular accident, TIA transient ischemic attack